Semenogelins in the human retina: Differences in distribution and content between AMD and normal donor tissues

Experimental Eye Research

Volumn 86, Issue 1, 2008, Pages 150-156

  Bonilha, Vera L ^a   Rayborn, Mary E ^a   Shadrach, Karen G ^a   Li, Yong ^a   Lundwall, Åke ^b   Malm, Johan ^b   Hollyfield, Joe G ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

AMD; immunohistochemistry; retina; semenogelins; zinc

Indexed keywords

SEMENOGELIN PROTEIN 1; SEMENOGELIN PROTEIN 2; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MEMBRANE STRUCTURE; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION;

BLOTTING, WESTERN; EYE PROTEINS; HUMANS; MACULAR DEGENERATION; PHOTORECEPTORS, VERTEBRATE; PIGMENT EPITHELIUM OF EYE; RETINA; RETINAL DRUSEN; SEMINAL VESICLE SECRETORY PROTEINS;

EID: 36749036652     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.10.006     Document Type: Article

References (29)

1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch. Ophthalmol. 119 (2001) 1417-1436
2. Anderson D.H., Talaga K.C., Rivest A.J., Barron E., Hageman G.S., and Johnson L.V. Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res. 78 (2004) 243-256
3. Bando H., Shadrach K.G., Rayborn M.E., Crabb J.W., and Hollyfield J.G. Clathrin and adaptin accumulation in drusen, Bruch's membrane and choroid in AMD and non-AMD donor eyes. Exp. Eye Res. 84 (2007) 135-142
4. Bjartell A., Malm J., Moller C., Gunnarsson M., Lundwell A., and Lilja H. Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry. J Androl. 17 (1996) 17-26
5. Bonilha V.L., Rayborn M.E., Shadrach K.G., Lundwall A., Malm J., Bhattacharya S.K., and Crabb J.W. Characterization of semenogelin proteins in the human retina. Exp. Eye Res. 83 (2006) 120-127
6. Clemons T.E., Milton R.C., Klein R., Seddon J.M., and Ferris III F.L. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112 (2005) 533-539
7. Hienonen T., Sammalkorpi H., Enholm S., Alhopuro P., Barber T.D., Lehtonen R., Nupponen N.N., Lehtonen H., Salovaara R., Mecklin J.P., Jarvinen H., Koistinen R., Arango D., Launonen V., Vogelstein B., Karhu A., and Aaltonen L.A. Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers. Cancer Res. 65 (2005) 4607-4613
8. Jonsson M., Linse S., Frohm B., Lundwall A., and Malm J. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem. J. 387 (2005) 447-453
9. Karcioglu Z.A. Zinc in the eye. Surv. Ophthalmol. 27 (1982) 114-122
10. de Lamirande E. Semenogelin, the main protein of semen coagulum, regulates sperm function. Semin. Thromb. Hemost. 33 (2007) 60-68
11. de Lamirande E., Yoshida K., Yoshiike T.M., Iwamoto T., and Gagnon C. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process. J. Androl. 22 (2001) 672-679
12. Lengyel I., Flinn J.M., Peto T., Linkous D.H., Cano K., Bird A.C., Lanzirotti A., Frederickson C.J., and van Kuijk F.J.G.M. High concentration of zinc in sub-retinal pigment epithelial deposits. Exp. Eye Res. 84 (2007) 772-780
13. Leure-duPree A.E., and McClain C.J. The effect of severe zinc deficiency on the morphology of the rat retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 23 (1982) 425-434
14. Lilja H., Abrahamsson P.A., and Lundwall A. Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J. Biol. Chem. 264 (1989) 1894-1900
15. Lilja H., and Laurell C.B. The predominant protein in human seminal coagulate. Scand. J. Clin. Lab. Invest. 45 (1985) 635-641
16. Lilja H., and Lundwall A. Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4559-4563
17. Linke R.P., Joswig R., Murphy C.L., Wang S., Zhou H., Gross U., Rocken C., Westermark P., Weiss D.T., and Solomon A. Senile seminal vesicle amyloid is derived from semenogelin I. J. Lab. Clin. Med. 145 (2005) 187-193
18. Lundwall A., Bjartell A., Olsson A.Y., and Malm J. Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues. Mol. Hum. Reprod. 8 (2002) 805-810
19. Malm J., Hellman J., Magnusson H., Laurell C.B., and Lilja H. Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II. Eur. J. Biochem. 238 (1996) 48-53
20. Miceli M.V., Tate Jr. D.J., Alcock N.W., and Newsome D.A. Zinc deficiency and oxidative stress in the retina of pigmented rats. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1238-1244
21. Nakata K., Crabb J.W., and Hollyfield J.G. Crystallin distribution in Bruch's membrane-choroid complex from AMD and age-matched donor eyes. Exp. Eye Res. 80 (2005) 821-826
22. Newsome D.A., Swartz M., Leone N.C., Elston R.C., and Miller E. Oral zinc in macular degeneration. Arch. Ophthalmol. 106 (1988) 192-198
23. Newsome D.A., Tate Jr. D.J., Alcock N.W., and Oliver P.D. Zinc content of human retinal pigment epithelium (RPE) declines with age. Invest. Ophthalmol. Vis. Sci. 35 Suppl (1994) 1768
24. Penfold P.L., Madigan M.C., Gillies M.C., and Provis J.M. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 20 (2001) 385-414
25. Robert M., and Gagnon C. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin. Biol. Reprod. 55 (1996) 813-821
26. Rodrigues R.G., Panizo-Santos A., Cashel J.A., Krutzsch H.C., Merino M.J., and Roberts D.D. Semenogelins are ectopically expressed in small cell lung carcinoma. Clin. Cancer Res. 7 (2001) 854-860
27. Schmidt-Erfurth U. Nutrition and retina. Dev. Ophthalmol. 38 (2005) 120-147
28. Yoshida T., Ohno-Matsui K., Ichinose S., Sato T., Iwata N., Saido T.C., Hisatomi T., Mochizuki M., and Morita I. The potential role of amyloid β in the pathogenesis of age-related macular degeneration. J. Clin. Invest. 115 (2005) 2793-2800
29. Zhang Y., Wang Z., Liu H., Giles F.J., and Lim S.H. Pattern of gene expression and immune responses to Semenogelin 1 in chronic hematologic malignancies. J Immunother. 26 (2003) 461-467